
Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 23, 2025, titled "Stellar Financial & Operational Performance for Q3 & 9MFY25".
Filed with NSE ·

Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 23, 2025, titled "Stellar Financial & Operational Performance for Q3 & 9MFY25".
6ix hasn’t read this filing yet.
Senores Pharmaceuticals Ltd. on 6ix
Follow Senores Pharmaceuticals into a list and get an email when it puts out news.
Follow Senores Pharmaceuticals